scholarly article | Q13442814 |
P356 | DOI | 10.1161/01.CIR.0000032135.98011.C4 |
P698 | PubMed publication ID | 12208790 |
P50 | author | Peter Wilson | Q89854449 |
Christopher J O'Donnell | Q89928448 | ||
Warren J. Manning | Q92757362 | ||
Michelle J Kupka | Q114427828 | ||
Melvin E Clouse | Q114427829 | ||
Emelia J. Benjamin | Q28754501 | ||
Martin G Larson | Q37390385 | ||
Ralph B. D'Agostino Sr. | Q59209521 | ||
Thomas J. Wang | Q80460150 | ||
Daniel Levy | Q88264418 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1189-1191 | |
P577 | publication date | 2002-09-01 | |
P1433 | published in | Circulation | Q578091 |
P1476 | title | C-reactive protein is associated with subclinical epicardial coronary calcification in men and women: the Framingham Heart Study | |
P478 | volume | 106 |
Q35953397 | "Missing" inhibitors of calcification: general aspects and implications in renal failure |
Q30494320 | A high sensitivity assay for the inflammatory marker C-Reactive protein employing acoustic biosensing. |
Q34180999 | Acculturative stress and inflammation among Chinese immigrant women |
Q35139924 | Analytical performance of a highly sensitive C-reactive protein-based immunoassay and the effects of laboratory variables on levels of protein in blood |
Q33689552 | Application of machine learning algorithms to predict coronary artery calcification with a sibship-based design |
Q37041028 | Association between C-reactive protein and coronary calcium score in coronary artery disease. |
Q36842378 | Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD. |
Q24297939 | Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study |
Q41238717 | Association of systemic inflammation with epicardial fat and coronary artery calcification |
Q45152907 | Association of traditional and nontraditional cardiovascular risk factors with coronary artery calcification |
Q33695638 | Associations of inflammatory markers with coronary artery calcification: results from the Multi-Ethnic Study of Atherosclerosis |
Q37457593 | Atherosclerotic biomarkers and aortic atherosclerosis by cardiovascular magnetic resonance imaging in the Framingham Heart Study |
Q57565715 | Body morphology differentially predicts coronary calcium |
Q35562701 | C-reactive protein and cardiovascular disease: new insights from an old molecule |
Q36928407 | C-reactive protein and coronary artery calcium in asymptomatic women with systemic lupus erythematosus or rheumatoid arthritis |
Q34552689 | C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study |
Q35158958 | C-reactive protein and subclinical cardiovascular disease among African-Americans: (the Jackson Heart Study). |
Q36408376 | C-reactive protein, inflammatory conditions, and cardiovascular disease risk |
Q44494762 | Cardiovascular mortality and C-reactive protein in elderly patients beginning dialysis: reverse epidemiology? |
Q36013453 | Comparison of characteristics of future myocardial infarctions in women with baseline high versus baseline low levels of high-sensitivity C-reactive protein |
Q55330850 | Conditioned medium from bone marrow-derived mesenchymal stem cells inhibits vascular calcification through blockade of the BMP2-Smad1/5/8 signaling pathway. |
Q37206907 | Coronary arterial calcification in rheumatoid arthritis: comparison with the Multi-Ethnic Study of Atherosclerosis |
Q35672310 | Coronary calcification score: the coronary-risk impact factor |
Q33851934 | Coronary plaque type and burden by computed tomography angiography without association to C-reactive protein |
Q34517825 | Correlates of coronary artery calcified plaque in blacks and whites with type 2 diabetes |
Q37994308 | Developing and assessing cardiovascular biomarkers |
Q35797168 | Differences in Cardiometabolic Risk between Insulin-Sensitive and Insulin-Resistant Overweight and Obese Children |
Q34996608 | Differential associations between blood biomarkers of inflammation, oxidation, and lipid metabolism with varying forms of coronary atherosclerotic plaque as quantified by coronary CT angiography |
Q39851803 | Do cytokines induce vascular calcification by the mere stimulation of TNAP activity? |
Q38776273 | Does statins promote vascular calcification in chronic kidney disease? |
Q35696526 | Dyslipidemia treatment: current considerations and unmet needs |
Q35230060 | Effect of oral and vaginal hormonal contraceptives on inflammatory blood biomarkers |
Q48526535 | European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted |
Q48525600 | European guidelines on cardiovascular disease prevention in clinical practice (version 2012) : the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constitute |
Q34420387 | Gender differences in the association of C-reactive protein with coronary artery calcium in type-2 diabetes |
Q35953391 | Impact of inflammation and oxidative stress on vascular calcifications in chronic kidney disease |
Q99403369 | Inactive matrix Gla protein is elevated in patients with inflammatory bowel disease |
Q36058974 | Increased prevalence of subclinical atherosclerosis in rheumatoid arthritis patients of Indian descent. |
Q50172081 | Inflammation and coronary artery calcification in South Asians: The Mediators of Atherosclerosis in South Asians Living in America (MASALA) study. |
Q38369098 | Inflammation: a culprit for vascular calcification in atherosclerosis and diabetes |
Q33482833 | Levels of C-reactive protein associated with high and very high cardiovascular risk are prevalent in patients with rheumatoid arthritis |
Q36925289 | Matrix Gla protein is associated with risk factors for atherosclerosis but not with coronary artery calcification |
Q43269154 | Non-surgical periodontal therapy lowers serum inflammatory markers: a pilot study. |
Q38187956 | Obesity and cardiovascular outcomes: a review |
Q47205862 | Particulate matter exposure in cars is associated with cardiovascular effects in healthy young men. |
Q47169033 | Periodontal Therapy with 0.25%Lemongrass Oil Mouthwash in Reducing Risk of Cardiovascular Diseases: A 3-Arm Prospective Parallel Experimental Study |
Q37519710 | Pharmacotherapy of coronary atherosclerosis |
Q53487070 | Plasma cytokines, metabolic syndrome, and atherosclerosis in humans. |
Q44408652 | Plasma fibronectin level and its association with coronary artery disease and carotid intima-media thickness |
Q36942224 | Prospective association between inflammatory markers and progression of coronary artery calcification in adults with and without type 1 diabetes |
Q73614944 | Relation of C-reactive protein and fibrinogen to coronary artery calcium in subjects with systemic hypertension |
Q34893465 | Relationship among circulating inflammatory proteins, platelet gene expression, and cardiovascular risk |
Q33984012 | Statin Therapy for Primary Prevention of Atrial Fibrillation: Guided by CHADS2/CHA2DS2VASc Score |
Q81926211 | The association of sudden cardiac death with inflammation and other traditional risk factors |
Q46725792 | The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease |
Q90313625 | The impact of C-reactive protein levels on headache frequency in the HUNT study 2006-2008 |
Q36919239 | The importance of functional tests in personalized medicine |
Q53081279 | Use of B-mode ultrasound to examine preclinical markers of atherosclerosis: image quality may bias associations between adiposity and measures of vascular structure and function. |
Q82980042 | [Inflammation and vascular calcifications] |
Search more.